; (2) reclassifying benefits with respect to anticancer medications in a way that would increase such costs; or (3) applying more restrictive limitations on prescribed orally administered anticancer medications than on intravenously administered or injected anticancer medications. (d) Construction Nothing in this section shall be construed— (1) to require the use of orally administered anticancer medications as a replacement for other anticancer medications; (2) to prohibit a group health plan (or health insurance coverage offered in connection with such a plan) from requiring prior authorization or imposing other appropriate utilization controls in approving coverage for any chemotherapy; or (3) to supersede a State law that provides greater protections with respect to the coverage with respect to orally administered anticancer medications than is provided under this section. (e) Cost-Sharing defined In this section, the term cost-sharing includes a deductible, coinsurance, copayment, and any maximum limitation on the application of such a deductible, coinsurance, copayment, and similar out-of-pocket expenses. . (b) Technical Correction